Revance Therapeutics | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
AbbVie USD 5.52B 1.73B 2024-12
ALKERMES USD 399.81M 108.66M 2025-03
Bristol-Myers Squibb USD 10.88B 529M 2025-03
Eli Lilly USD 3.09B 175.1M 2025-03
J&J USD 38.47B 32.35B 2025-03
Merck USD 8.63B 4.61B 2025-03
Neurocrine Biosciences USD 233M 116.1M 2024-12
P&G USD 9.12B 1.11B 2025-03
Pacira USD 283.61M 6.84M 2025-03
Supernus Pharmaceuticals USD 69.33M 37.66M 2024-12



Revance Therapeutics Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.